Applications for liposomes in human malignancy: current status and future directions
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | Undetermined |
| Veröffentlicht: |
New York [u.a.]
Springer [u.a.]
1995
|
| Schriftenreihe: | Medical intelligence unit
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | 178 S. Ill., graph. Darst. |
| ISBN: | 157059290X 354060197X |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV010490106 | ||
| 003 | DE-604 | ||
| 007 | t| | ||
| 008 | 951122s1995 xx ad|| |||| 00||| undod | ||
| 020 | |a 157059290X |9 1-57059-290-X | ||
| 020 | |a 354060197X |9 3-540-60197-X | ||
| 035 | |a (OCoLC)845035765 | ||
| 035 | |a (DE-599)BVBBV010490106 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | |a und | ||
| 049 | |a DE-355 |a DE-29 |a DE-12 | ||
| 084 | |a XI 7000 |0 (DE-625)153024:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Applications for liposomes in human malignancy |b current status and future directions |c Steven Sugarman ... |
| 264 | 1 | |a New York [u.a.] |b Springer [u.a.] |c 1995 | |
| 300 | |a 178 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Medical intelligence unit | |
| 650 | 0 | 7 | |a Arzneistoffträger |0 (DE-588)4278196-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Liposom |0 (DE-588)4122262-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 0 | 1 | |a Liposom |0 (DE-588)4122262-3 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 1 | 1 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 1 | 2 | |a Liposom |0 (DE-588)4122262-3 |D s |
| 689 | 1 | 3 | |a Arzneistoffträger |0 (DE-588)4278196-6 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Sugarman, Steven |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006989459&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-006989459 | |
Datensatz im Suchindex
| _version_ | 1823607492482957312 |
|---|---|
| adam_text |
MEDICAL INTELLIGENCE UNIT APPLICATIONS FOR LIPOSOMES IN HUMAN
MALIGNANCY: CURRENT STATUS AND FUTURE DIRECTIONS STEVEN SUGARMAN, M.D.
STATE UNIVERSITY OF NEW YORK STONY BROOK, NEW YORK, U.S.A. ROMAN
PEREZ-SOLER, M.D. UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER
HOUSTON, TEXAS, U.S.A. SPRINGER NEW YORK BERLIN HEIDELBERG LONDON PARIS
R-G. LANDES COMPANY TOKYO HONG KONG BARCELONA BUDAPEST AUSTIN CONTENTS
1. THE USE OF LIPOSOMES AS DELIVERY VEHICLES IN BIOLOGICAL SYSTEMS 1
ROMAN PEREZ-SOLER INTRODUCTION 1 DEFINITION OF LIPOSOMES 2 ROLE OF LIPID
COMPOSITION 4 LIPOSOMES AS DRUG DELIVERY SYSTEMS IN THE 1990S 5
LIPOSOMES AS DRUG DELIVERY SYSTEMS IN THE 21ST CENTURY 14 2. DIAGNOSTIC
APPLICATIONS FOR LIPOSOMES IN HUMAN MALIGNANCY 17 STEVEN SUGARMAN
INTRODUCTION 17 ANTIBODY-BEARING LIPOSOMES FOR TISSUE PATHOLOGY 17
DIAGNOSTIC IMAGING 19 IMAGING WITH LIPOSOMAL CT CONTRAST-ENHANCING
AGENTS 19 LIPOSOMAL MR-ENHANCING CONTRAST AGENTS 20 TUMOR IMAGING WITH
LIPOSOMAL RADIONUCLIDES 24 IMAGING IN VIVO LIPOSOME DISTRIBUTION BY
ELECTRON MICROSCOPY 35 3. THE USE OF LIPOSOMES FOR TREATING INFECTIOUS
DISEASES IN CANCER PATIENTS 41 KISHOR M. WASAN AND GABRIEL
LOPEZ-BERESTEIN INTRODUCTION 41 TARGETING TO INTRACELLULAR INFECTIONS 43
TARGETING TO EXTRACELLULAR INFECTIONS 45 CLINICAL APPLICATIONS IN CANCER
PATIENTS 47 FUTURE USES OF LIPOSOMES IN INFECTIOUS DISEASES 54 DIRECTED
TARGETING TO DISEASE SITES 56 SUMMARY 56 4. CLINICAL STUDIES USING
LIPOSOMAL FORMULATIONS OF ANTHRACYCLINES 63 STEVEN SUGARMAN INTRODUCTION
63 PHASE I STUDIES OF STNADARD LIPOSOMES CONTAINING DOXORUBICIN 65 PHASE
II STUDIES OF LIPOSOMES CONTAINING ANTHRACYCLINES 72 LONG-CIRCULATING
LIPOSOMAL DOXORUBICIN 74 INTRAPERITONEAL LIPOSOMAL DOXORUBICIN 76
LIPOSOMAL DAUNORUBICIN 78 LIPOSOMAL MITOXANTRONE 78 THE TREATMENT OF
KAPOSI'S SARCOMA (KS) WITH LIPOSOMAL ANTHRACYCLINES 80 5* CLINICAL
STUDIES USING LIPOSOMAL FORMULATIONS OF NON-ANTHRACYDINE ANTINEOPLASTIC
AGENTS 87 STEVEN SUGARMAN INVESTIGATIONAL WATER-INSOLUBLE COMPOUNDS 87
LIPOSOMAL CISPLATIN ANALOG 90 LIPOSOME-ASSOCIATED RETINOIC ACID 91
LIPOSOMAL ANTITUMOR AGENTS IN PRECLINICAL DEVELOPMENT 93 6. CLINICAL
STUDIES USING LIPOSOMAL FORMULATIONS OF IMMUNO MODULATORS 101 STEVEN
SUGARMAN INTRODUCTION 101 CLINICAL TRIALS USING LIPOSOMAL MACROPHAGE
ACTIVATORS 102 COMBINING LIPOSOMAL IMMUNOMODULATORS WITH CHEMOTHERAPY
ILL LIPOSOMAL TUMOR-ASSOCIATED ANTIGENS 112 SUMMARY 113 7. USING
LIPOSOMES TO OVERCOME DRUG RESISTANCE 117 STEVEN SUGARMAN DOXORUBICIN
119 DOXORUBICIN PLUS HYPERTHERMIA 121 DAUNOMYCIN 123 ANNAMYCIN 123
EPIRUBICIN 125 VINABLASTINE 125 PACLITAXEL 125 LIPOSOMAL CISPLATIN
ANALOG 126 INTERFERON 126 TUMOR NECROSIS FACTOR-ALPHA 127
ALL-*RA.Y-RETINOIC ACID 128 ANTISENSE OLIGONUDEOTIDES TO OVERCOME DRUG
RESISTANCE 128 8. LIPOSOMAL TARGETING STRATEGIES 135 DENNIE V. JONES,
JR. 9. LIPOSOMES IN NUCLEIC ACID TRANSFECTION 153 DENNIE V. JONES, JR.
IN VITRO AND IN VIVO STUDIES 153 INDEX 173 |
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV010490106 |
| classification_rvk | XI 7000 |
| ctrlnum | (OCoLC)845035765 (DE-599)BVBBV010490106 |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV010490106</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">951122s1995 xx ad|| |||| 00||| undod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">157059290X</subfield><subfield code="9">1-57059-290-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">354060197X</subfield><subfield code="9">3-540-60197-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)845035765</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010490106</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">und</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 7000</subfield><subfield code="0">(DE-625)153024:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Applications for liposomes in human malignancy</subfield><subfield code="b">current status and future directions</subfield><subfield code="c">Steven Sugarman ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Springer [u.a.]</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">178 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Medical intelligence unit</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneistoffträger</subfield><subfield code="0">(DE-588)4278196-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Liposom</subfield><subfield code="0">(DE-588)4122262-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Liposom</subfield><subfield code="0">(DE-588)4122262-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Liposom</subfield><subfield code="0">(DE-588)4122262-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Arzneistoffträger</subfield><subfield code="0">(DE-588)4278196-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sugarman, Steven</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006989459&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006989459</subfield></datafield></record></collection> |
| id | DE-604.BV010490106 |
| illustrated | Illustrated |
| indexdate | 2025-02-09T19:00:28Z |
| institution | BVB |
| isbn | 157059290X 354060197X |
| language | Undetermined |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006989459 |
| oclc_num | 845035765 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-29 DE-12 |
| owner_facet | DE-355 DE-BY-UBR DE-29 DE-12 |
| physical | 178 S. Ill., graph. Darst. |
| publishDate | 1995 |
| publishDateSearch | 1995 |
| publishDateSort | 1995 |
| publisher | Springer [u.a.] |
| record_format | marc |
| series2 | Medical intelligence unit |
| spelling | Applications for liposomes in human malignancy current status and future directions Steven Sugarman ... New York [u.a.] Springer [u.a.] 1995 178 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Medical intelligence unit Arzneistoffträger (DE-588)4278196-6 gnd rswk-swf Cytostatikum (DE-588)4068347-3 gnd rswk-swf Liposom (DE-588)4122262-3 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Cytostatikum (DE-588)4068347-3 s Liposom (DE-588)4122262-3 s DE-604 Krebs Medizin (DE-588)4073781-0 s Arzneistoffträger (DE-588)4278196-6 s Sugarman, Steven Sonstige oth GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006989459&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Applications for liposomes in human malignancy current status and future directions Arzneistoffträger (DE-588)4278196-6 gnd Cytostatikum (DE-588)4068347-3 gnd Liposom (DE-588)4122262-3 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| subject_GND | (DE-588)4278196-6 (DE-588)4068347-3 (DE-588)4122262-3 (DE-588)4073781-0 |
| title | Applications for liposomes in human malignancy current status and future directions |
| title_auth | Applications for liposomes in human malignancy current status and future directions |
| title_exact_search | Applications for liposomes in human malignancy current status and future directions |
| title_full | Applications for liposomes in human malignancy current status and future directions Steven Sugarman ... |
| title_fullStr | Applications for liposomes in human malignancy current status and future directions Steven Sugarman ... |
| title_full_unstemmed | Applications for liposomes in human malignancy current status and future directions Steven Sugarman ... |
| title_short | Applications for liposomes in human malignancy |
| title_sort | applications for liposomes in human malignancy current status and future directions |
| title_sub | current status and future directions |
| topic | Arzneistoffträger (DE-588)4278196-6 gnd Cytostatikum (DE-588)4068347-3 gnd Liposom (DE-588)4122262-3 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| topic_facet | Arzneistoffträger Cytostatikum Liposom Krebs Medizin |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006989459&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT sugarmansteven applicationsforliposomesinhumanmalignancycurrentstatusandfuturedirections |